Table 4 Ultrasound Parameters of Malignancy of the 143 Patients that underwent Thyroid Nodule Evaluation in a Single Center
From: Role of ultrasound, clinical and scintigraphyc parameters to predict malignancy in thyroid nodule
Variables | Benign | Malign | P-value | ||
|---|---|---|---|---|---|
N | % | N | % | ||
Nodules (n) | 93 | 50 | |||
Nodule (number)/patient | 1.58 ± 1.15 | 1.73 ± 1.31 | 0.51 | ||
Nodule size (cm) | 2.87 ± 1.65 | 2.23 ± 1.82 | 0.003 | ||
Nodule size (range) [cm] | 0.3 - 9.3 | 0.3 - 9.0 | |||
Microcalcifications | 12 | 14.1% | 20 | 45.5% | < 0.001 |
Macrocalcifications | 15 | 17.6% | 04 | 9.09% | 0.06 |
Border Irregularity | 15 | 17.8% | 34 | 75.5% | < 0.001 |
Hypoechogenicity | 36 | 42.3% | 32 | 71.1% | 0.003 |
Hyperechogenicity | 31 | 36.4% | 06 | 13.3% | 0.001 |
Size ≥ 2 cm | 64 | 73.5% | 23 | 46.0% | 0.001 |
Internal Flow | 13 | 21.6% | 17 | 56.6% | < 0.001 |
Absent Flow | 27 | 45.0% | 06 | 20.0% | < 0.001 |